-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $26

Benzinga·08/07/2026 20:19:16
Listen to the news
RBC Capital analyst Kendall Au maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform and lowers the price target from $30 to $26.